000			02039 a2200673 4500
005			20250514011840.0
264		0	_c20011011
008			200110s 0 0 eng d
022			_a0344-5704
024	7		_a10.1007/s002800100305 _2doi
040			_aNLM _beng _cNLM
100	1		_aBüchner, T
245	0	0	_aRemission induction therapy: the more intensive the better? _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _cAug 2001
300			_aS41-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aClinical Trials as Topic
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aRemission Induction
650	0	4	_aThioguanine _xadministration & dosage
700	1		_aHiddemann, W
700	1		_aBerdel, W
700	1		_aWörmann, B
700	1		_aLöffler, H
700	1		_aSchoch, C
700	1		_aHaferlach, T
700	1		_aLudwig, W D
700	1		_aMaschmeyer, G
700	1		_aStaib, P
700	1		_aAndreesen, R
700	1		_aBalleisen, L
700	1		_aHaase, D
700	1		_aEimermacher, H
700	1		_aAul, C
700	1		_aRasche, H
700	1		_aUhlig, J
700	1		_aGrüneisen, A
700	1		_aReis, H E
700	1		_aHartlapp, J
700	1		_aHirschmann, W D
700	1		_aWeh, H J
700	1		_aPielken, H J
700	1		_aGassmann, W
700	1		_aSauerland, M C
700	1		_aHeinecke, A
773	0		_tCancer chemotherapy and pharmacology _gvol. 48 Suppl 1 _gp. S41-4
856	4	0	_uhttps://doi.org/10.1007/s002800100305 _zAvailable from publisher's website
999			_c11507757 _d11507757